The Supreme Court of Canada has rejected the promise doctrine, which lawyers say will have significant repercussions for patent law.
The case — AstraZeneca Canada Inc. et al. v. Apotex Inc. et al. — pitted two drug companies against each other over a patent.
The patent related to the “optically pure salts of esomeprazole,” which helps people with issues like gastric acid.